Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Trillium Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Trillium Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Trillium Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Trillium Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Trillium Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 10
Trillium Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Trillium Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Fluorinov Pharma Raises US$1.5 Million In Venture Financing 12
Merger 13
Stem Cell Therapeutics Completes Merger With Trillium Therapeutics 13
Licensing Agreements 14
Trillium Therapeutics Amends Licensing Agreement with University Health Network 14
Stem Cell Therapeutics Enters Into Licensing Agreement With MaRS Innovation For Cancer Stem Cell Program 16
StemCell Technologies Enters Into Licensing Agreement With HUB Foundation for Organoid Technology 18
Stem Cell Therapeutics Enters Into Option For Licensing Agreement With University Of Toronto 19
Stem Cell Therapeutics Enters Into Option For Licensing Agreement With University of York For Prostate Cancer Stem Cell Assets 21
StemCell Technologies Enters Into Licensing Agreement With iPS Academia Japan For Induced Pluripotent Stem Cell Technologies 22
Equity Offering 23
Trillium Therapeutics Files Shelf Prospectus to Raise up to USD150 Million 23
Trillium Therapeutics Raises USD20 Million in Private Placement of Shares 24
Trillium Therapeutics Completes Underwriters’ Partial Exercise of Over-Allotment Option of Public Offering of Shares and Prefererd Shares for USD31 Million 25
Trillium Therapeutics Raises USD55.2 Million in Public Offering of Shares 27
Stem Cell Therapeutics Completes Private Placement Of Shares For US$31 Million 28
Stem Cell Therapeutics Completes Public Offering Of Units For US$3.2 Million 30
Acquisition 31
Trillium Therapeutics Acquires Fluorinov Pharma 31
Trillium Therapeutics Inc – Key Competitors 32
Trillium Therapeutics Inc – Key Employees 33
Trillium Therapeutics Inc – Locations And Subsidiaries 34
Head Office 34
Other Locations & Subsidiaries 34
Recent Developments 35
Financial Announcements 35
Aug 08, 2018: Trillium Therapeutics reports second quarter 2018 financial and operating results 35
May 11, 2018: Trillium Therapeutics Reports First Quarter 2018 Financial and Operating Results 36
Mar 09, 2018: Trillium Therapeutics Reports Annual 2017 Financial And Operating Results 37
Nov 10, 2017: Trillium Therapeutics Reports Third Quarter 2017 Financial and Operating Results 38
Aug 11, 2017: Trillium Therapeutics Reports Second Quarter 2017 Financial and Operating Results 39
May 12, 2017: Trillium Reports First Quarter 2017 Financial and Operating Results 40
Mar 10, 2017: Trillium Therapeutics Reports Annual 2016 Financial and Operating Results 41
Corporate Communications 42
Jun 07, 2018: Trillium Therapeutics Appoints Yaping Shou, MD, PhD as Chief Medical Officer 42
Product News 43
07/05/2017: Trillium Provides Update on TTI-2341 EGFR Inhibitor Program 43
04/10/2018: Trillium Therapeutics Provides Update on TTI-622 Program 44
Clinical Trials 45
Nov 20, 2017: Trillium Therapeutics TTI-2341 EGFR Inhibitor Program Featured at the Society for Neuro-Oncology 22nd Annual Meeting 45
Feb 02, 2017: Trillium Therapeutics Provides Update On TTI-622 46
Appendix 47
Methodology 47
About GlobalData 47
Contact Us 47
Disclaimer 47
Trillium Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Trillium Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Trillium Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Trillium Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Trillium Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Trillium Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 10
Trillium Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Fluorinov Pharma Raises US$1.5 Million In Venture Financing 12
Stem Cell Therapeutics Completes Merger With Trillium Therapeutics 13
Trillium Therapeutics Amends Licensing Agreement with University Health Network 14
Stem Cell Therapeutics Enters Into Licensing Agreement With MaRS Innovation For Cancer Stem Cell Program 16
StemCell Technologies Enters Into Licensing Agreement With HUB Foundation for Organoid Technology 18
Stem Cell Therapeutics Enters Into Option For Licensing Agreement With University Of Toronto 19
Stem Cell Therapeutics Enters Into Option For Licensing Agreement With University of York For Prostate Cancer Stem Cell Assets 21
StemCell Technologies Enters Into Licensing Agreement With iPS Academia Japan For Induced Pluripotent Stem Cell Technologies 22
Trillium Therapeutics Files Shelf Prospectus to Raise up to USD150 Million 23
Trillium Therapeutics Raises USD20 Million in Private Placement of Shares 24
Trillium Therapeutics Completes Underwriters' Partial Exercise of Over-Allotment Option of Public Offering of Shares and Prefererd Shares for USD31 Million 25
Trillium Therapeutics Raises USD55.2 Million in Public Offering of Shares 27
Stem Cell Therapeutics Completes Private Placement Of Shares For US$31 Million 28
Stem Cell Therapeutics Completes Public Offering Of Units For US$3.2 Million 30
Trillium Therapeutics Acquires Fluorinov Pharma 31
Trillium Therapeutics Inc, Key Competitors 32
Trillium Therapeutics Inc, Key Employees 33
Trillium Therapeutics Inc, Subsidiaries 34
List of Figures
Trillium Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Trillium Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Trillium Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Trillium Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Trillium Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Trillium Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Trillium Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Trillium Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Trillium Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 10